|
Volumn 12, Issue 2, 2013, Pages 127-128
|
Prescribing of psychotropic medications to children and adolescents: Quo vadis?
a,b,c d,e f
f
NONE
(United States)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
GENERIC DRUG;
PSYCHOTROPIC AGENT;
CENTRAL NERVOUS SYSTEM DISEASE;
CHILD PSYCHIATRY;
DRUG EFFICACY;
DRUG INDUSTRY;
DRUG TOLERABILITY;
EVIDENCE BASED PRACTICE;
FINANCIAL DEFICIT;
HEALTH CARE MANPOWER;
HUMAN;
MEDICAL RESEARCH;
MENTAL DISEASE;
NOTE;
OFF LABEL DRUG USE;
PRESCRIPTION;
PRIORITY JOURNAL;
PRIVATE HEALTH INSURANCE;
PSYCHOPHARMACOLOGY;
PSYCHOPHARMACOTHERAPY;
PSYCHOTHERAPIST;
PSYCHOTHERAPY;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
|
EID: 84878537365
PISSN: 17238617
EISSN: 20515545
Source Type: Journal
DOI: 10.1002/wps.20031 Document Type: Note |
Times cited : (7)
|
References (7)
|